Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Conduct and oppositional problems

Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Violence or exploitation needs a safety response

Immediate threats with weapons, serious assault, fire-setting, cruelty, dangerous absconding, exploitation, acute intoxication, suicidal behaviour, psychosis or inability of carers to keep anyone safe requires urgent multi-agency risk management rather than a routine behaviour appointment.

Action: Protect those present, call emergency services when danger is immediate, assess injuries, substances, mental state and access to weapons, and involve CAMHS, safeguarding, social care and police through local procedures as indicated. Use the least restrictive safe response, speak with the child privately when possible and do not return them to a potentially abusive or exploitative setting without a plan.

Synopsis

Assess persistent oppositional or conduct problems developmentally and without blame, identify neurodevelopmental, trauma, family and safeguarding needs, distinguish immediate danger from chronic difficulty, and deliver evidence-based parent, child and multimodal interventions.

  • Describe specific behaviours, frequency, settings, development and impact rather than calling a child difficult, manipulative, bad or antisocial.
  • Oppositional behaviour involves a persistent pattern of angry or irritable mood, argument and defiance beyond developmental expectations; conduct disorder includes repeated violation of others' rights or major age-appropriate rules.
  • Diagnosis requires persistence and impairment across context, not one conflict with an adult or a reaction to an unsafe, discriminatory or inaccessible environment.
  • Assess ADHD, autism, learning or language needs, depression, trauma, attachment, substance use, psychosis, physical illness and child maltreatment before attributing behaviour to conduct disorder.
  • A functional account maps antecedents, behaviour and consequences, including what the child communicates, obtains or escapes and how adults and peers respond.
  • NICE recommends group parent training for parents or carers of children aged 3–11 at high risk of or with oppositional defiant or conduct disorder.
  • For severe and complex problems aged 3–11, offer individual parent-and-child training; for ages 9–14 consider child-focused social and cognitive problem-solving.
  • For young people aged 11–17, multimodal interventions coordinate family, school, peers and community rather than relying on office therapy alone.
  • Do not routinely use medication for behavioural problems; treat coexisting ADHD appropriately and reserve short-term specialist risperidone consideration for narrowly defined severe aggression after psychosocial non-response.

Key red flags

Weapon access, credible threats, serious assault, strangulation, fire-setting or cruelty with immediate opportunity requires urgent safety assessment and restriction of access.

A sudden onset of aggression with reduced sleep, grandiosity, psychosis, confusion, seizure, head injury or intoxication suggests an acute disorder rather than a stable conduct pattern.

Criminal or sexual exploitation, trafficking, gang control, coercive older peers, unexplained money or repeated missing episodes are safeguarding concerns, not merely delinquency.

Injuries, fear of a carer, domestic abuse, harsh punishment, neglect or developmentally inappropriate responsibility requires private enquiry and safeguarding action.

Suicidal behaviour, severe self-harm, escalating substance use or profound school and relationship collapse can accompany externalising presentations and must be asked about directly.

Investigation priorities

01
Specific behavioural timelineFirst step

Define onset, frequency, severity, setting, triggers, consequences, harm and developmental fit.

Management branches

Initial formulationDescribe before diagnosing

Repeated conflict, aggression, rule breaking or irritability is reported by family, school or another service.

  1. Speak with the child and carers, define behaviours and developmental context, identify strengths and obtain cross-setting information with appropriate consent.
  2. Assess neurodevelopment, mental and physical health, trauma, substances, learning, family stress, school environment, exploitation and safeguarding.
  3. Share a non-blaming formulation that separates immediate safety action from longer-term skills, family and environmental intervention.

Key medicines

Risperidone for persistent severe aggression in conduct disorderFor children and adolescents aged 5 to 18 within the product-specific licensed scope: if body weight is 50 kg or more, start 0.5 mg orally once daily and, if needed, adjust by 0.5 mg no more often than every other day; the usual dose is 1 mg daily and the licensed range is 0.5 to 1.5 mg daily. If body weight is below 50 kg, start 0.25 mg orally once daily and, if needed, adjust by 0.25 mg no more often than every other day; the usual dose is 0.5 mg daily and the licensed range is 0.25 to 0.75 mg daily. Licensed treatment is short term, up to 6 weeks.Check the exact product licence: the cited SmPC limits licensed paediatric conduct-disorder use to ages 5 to 18 with subaverage intellectual functioning, so use outside that scope is off label. Assess pain and social or environmental causes first; monitor sedation and learning, weight and metabolism, movement, cardiovascular and prolactin-related effects. Review at 3 to 4 weeks and stop at 6 weeks if there is no clinically important response; halve starting and subsequent doses and titrate more slowly in renal or hepatic impairment.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG158 conduct disorder recommendationsAssessment, age-specific psychosocial programmes and exceptional medication safeguards.
  • NICE NG87 ADHD recommendationsRecognition and treatment of coexisting ADHD and monitoring.
  • NICE NG76 child abuse and neglectSafeguarding assessment and therapeutic work after maltreatment.
  • NICE CG89 child maltreatment recommendationsAlerting features, behavioural presentations and local safeguarding action.
  • Risperidone 1 mg/mL oral solution SmPCCurrent product-specific licensed population, weight-based oral dosing, six-week limit and paediatric cautions.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom